Randomized Clinical Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11415-11421
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11415
Figure 1
Figure 1 Study flow chart. Patients in Group 1 and Group 3 received rabeprazole (10 mg), amoxicillin (1000 mg) and furazolidone (100 mg) twice daily for 7 and 10 d, respectively. Patients in Group 2 and Group 4 received rabeprazole (10 mg), bismuth (220 mg), amoxicillin (1000 mg) and furazolidone (100 mg) twice daily for 7 and 10 d, respectively.